A novel multimeric vaccine demonstrates broad protection against infection in Gram-positive pathogens, indicating its potential efficacy.
These findings highlight the potential of ATOMSSUISpenta as a subunit vaccine strategy with potential for broader protection against S. suis and demonstrate the effectiveness of epitope-based multimeric design in targeting antigenically diverse Gram-positive pathogens.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: